LivingGLP1
Study S002240

Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes

Registration

Registration
NCT02016846
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
DOUBLE
Status
UNKNOWN
Enrollment
36
Start
2014-01
Primary completion
2015-01
Lead sponsor
Rabin Medical Center
Conditions
Glucocorticoid Induced Hyperglycemia
Interventions
DRUG:Liraglutide; DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • Glucose levels 2 hours after 75 gr OGTT [6 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.